PUBBLICAZIONI CLINICA METABOLICA
Pubblicazioni 2012
Le seguenti pubblicazioni sono state pubblicate nel corso dell’anno 2012
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.
Cossarizza A, Bertoncelli L, Nemes E, Lugli E, Pinti M, Nasi M, De Biasi S, Gibellini L, Montagna JP, Vecchia M, Manzini L, Meschiari M, Borghi V, Guaraldi G, Mussini C.
PLoS One. 2012;7(12):e50728. doi: 10.1371/journal.pone.0050728. Epub 2012 Dec 7.
Increase in standard cholesterol and large HDL particle subclasses in antiretroviral-naïve patients prescribed efavirenz compared to atazanavir/ritonavir.
Gotti D, Cesana BM, Albini L, Calabresi A, Izzo I, Focà E, Motta D, Bellagamba R, Fezza R, Narciso P, Sighinolfi L, Maggi P, Brianese N, Quiros-Roldan E, Guaraldi G, Torti C.
HIV Clin Trials. 2012 Sep-Oct;13(5):245-55. doi: 10.1310/hct1305-245.
Aseptic osteonecrosis: a newly diagnosed complication in HIV-infected patients undergoing liver transplantation.
Cocchi S, Franceschini E, Meschiari M, Codeluppi M, Rompianesi G, Di Benedetto F, Gerunda GE, Mussini C, Guaraldi G.
Transplantation. 2012 Aug 15;94(3):e20-1. doi: 10.1097/TP.0b013e31825fc0d2. No abstract available.
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.
Bucciardini R, D'Ettorre G, Baroncelli S, Ceccarelli G, Parruti G, Weimer LE, Fragola V, Galluzzo CM, Pirillo MF, Lucattini S, Bellagamba R, Francisci D, Ladisa N, Degli Antoni A, Guaraldi G, Manconi PE, Vullo V, Preziosi R, Cirioni O, Verucchi G, Floridia M; ISS-NIA study group.
Int J STD AIDS. 2012 Jul;23(7):459-63.
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities.
Guaraldi G, Besutti G, Stentarelli C, Zona S, Nocetti L, Loria P, Ballestri S, Losi L, Torricelli P, Ligabue G.
Antivir Ther. 2012;17(6):965-71. doi: 10.3851/IMP2228. Epub 2012 Jul 5.
Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV.
Zona S, Raggi P, Bagni P, Orlando G, Carli F, Ligabue G, Scaglioni R, Rossi R, Modena MG, Guaraldi G.
Am Heart J. 2012 Jun;163(6):1024-30. doi: 10.1016/j.ahj.2012.03.019.
Erectile dysfunction is more common in young to middle-aged HIV-infected men than in HIV-uninfected men.
Zona S, Guaraldi G, Luzi K, Beggi M, Santi D, Stentarelli C, Madeo B, Rochira V.
J Sex Med. 2012 Jul;9(7):1923-30. doi: 10.1111/j.1743-6109.2012.02750.x. Epub 2012 Apr 30.
Ectopic fat is linked to prior cardiovascular events in men with HIV.
Orlando G, Guaraldi G, Zona S, Carli F, Bagni P, Menozzi M, Cocchi S, Scaglioni R, Ligabue G, Raggi P.
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):494-7. doi: 10.1097/QAI.0b013e31824c8397.
Erratum in: J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):e120. Gabriella, Orlando [corrected to Orlando, Gabriella]; Giovanni, Guaraldi [corrected to Guaraldi, Giovanni]; Stefano, Zona [corrected to Zona, Stefano]; Federica, Carli [corrected to Carli, Federica]; Pietro, Bagni [corrected to Bagni, Pietro]; Marianna, Me.
Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.
Guaraldi G, Lonardo A, Ballestri S, Zona S, Stentarelli C, Orlando G, Carli F, Carulli L, Roverato A, Loria P.
Arch Med Res. 2011 Nov;42(8):690-7. doi: 10.1016/j.arcmed.2011.12.009. Epub 2012 Jan 4.
GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls.
Zirilli L, Orlando G, Carli F, Madeo B, Cocchi S, Diazzi C, Carani C, Guaraldi G, Rochira V.
Eur J Endocrinol. 2012 Mar;166(3):415-24. doi: 10.1530/EJE-11-0829. Epub 2011 Dec 21.
Long-term efficacy and safety of polyacrylamide hydrogel injection in the treatment of human immunodeficiency virus-related facial lipoatrophy: a 5-year follow-up.
De Santis G, Pignatti M, Baccarani A, Pedone A, Spaggiari A, Orlando G, Guaraldi G.
Plast Reconstr Surg. 2012 Jan;129(1):101-9. doi: 10.1097/PRS.0b013e3182362142.
Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease.
Triant VA, Josephson F, Rochester CG, Althoff KN, Marcus K, Munk R, Cooper C, D'Agostino RB, Costagliola D, Sabin CA, Williams PL, Hughes S, Post WS, Chandra-Strobos N, Guaraldi G, Young SS, Obenchain R, Bedimo R, Miller V, Strobos J.
Clin Infect Dis. 2012 Feb 1;54(3):408-13. doi: 10.1093/cid/cir829. Epub 2011 Nov 17.
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz.
Albini L, Cesana BM, Motta D, Focà E, Gotti D, Calabresi A, Izzo I, Bellagamba R, Fezza R, Narciso P, Sighinolfi L, Maggi P, Quiros-Roldan E, Manili L, Guaraldi G, Lapadula G, Torti C.
J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):18-30. doi: 10.1097/QAI.0b013e31823a6124.
High-density hyaluronic acid for the treatment of HIV-related facial lipoatrophy.
Pignatti M, Pedone A, Baccarani A, Guaraldi G, Orlando G, Lombardi M, De Santis G.
Aesthetic Plast Surg. 2012 Feb;36(1):180-5. doi: 10.1007/s00266-011-9771-3. Epub 2011 Jun 30.
Progression of coronary artery calcium in men affected by human immunodeficiency virus infection.
Guaraldi G, Zona S, Orlando G, Carli F, Ligabue G, Fiocchi F, Rossi R, Modena MG, Raggi P.
Int J Cardiovasc Imaging. 2012 Apr;28(4):935-41. doi: 10.1007/s10554-011-9898-y. Epub 2011 Jun 5.
Erectile dysfunction is not a mirror of endothelial dysfunction in HIV-infected patients.
Guaraldi G, Beggi M, Zona S, Luzi K, Orlando G, Carli F, Ligabue G, Rochira V, Rossi R, Modena MG, Bouloux P.
J Sex Med. 2012 Apr;9(4):1114-21. doi: 10.1111/j.1743-6109.2011.02243.x. Epub 2011 Apr 7.
TUTTE LE NOSTRE PUBBLICAZIONI
Siamo lieti
di accoglierti
Chiedici informazioni
o prenota la tua prima visita
presso la Clinica Metabolica
di Modena